iRGD Peptide as a Tumor-Penetrating Enhancer for Tumor-Targeted Drug Delivery
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
iRGD Peptide as a Tumor-Penetrating Enhancer for Tumor-Targeted Drug Delivery
Authors
Keywords
-
Journal
Polymers
Volume 12, Issue 9, Pages 1906
Publisher
MDPI AG
Online
2020-08-24
DOI
10.3390/polym12091906
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Burden of Pancreatic Cancer—From Epidemiology to Practice
- (2020) Natalia Khalaf et al. Clinical Gastroenterology and Hepatology
- Immunosurveillance and Immunoediting of Lung Cancer: Current Perspectives and Challenges
- (2020) Kei Kunimasa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Antitumor Activity of Thermosensitive Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating Peptide iRGD Against Gastric Cancer
- (2020) Dinghu Zhang et al. International Journal of Nanomedicine
- Relationship between neuropilin-1 expression and prognosis, according to gastric cancer histology
- (2020) Ho Seok Seo et al. JOURNAL OF MOLECULAR HISTOLOGY
- An iRGD peptide fused superantigen mutant induced tumor-targeting and T lymphocyte infiltrating in cancer immunotherapy
- (2020) Yubo Song et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016
- (2019) Kyu-Won Jung et al. Cancer Research and Treatment
- iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer
- (2019) Naiqing Ding et al. Nature Communications
- Improved Anticancer Effect of Recombinant Protein izTRAIL Combined with Sorafenib and Peptide iRGD
- (2019) Roman Fadeev et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Radiation-Induced Targeted Nanoparticle-Based Gene Delivery for Brain Tumor Therapy
- (2019) Gulsah Erel-Akbaba et al. ACS Nano
- Modification of IL-24 by tumor penetrating peptide iRGD enhanced its antitumor efficacy against non-small cell lung cancer
- (2019) Jie Yang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Multitargeted Nanoparticles Deliver Synergistic Drugs across the Blood-Brain Barrier to Brain Metastases of Triple Negative Breast Cancer Cells and Tumor-Associated Macrophages
- (2019) Tian Zhang et al. Advanced Healthcare Materials
- Smart Nanotherapeutic Targeting of Tumor Vasculature
- (2019) Zifu Li et al. ACCOUNTS OF CHEMICAL RESEARCH
- Modular Engineering of Targeted Dual-Drug Nanoassemblies for Cancer Chemoimmunotherapy
- (2019) Tianyi Kang et al. ACS Applied Materials & Interfaces
- Remarkable Boron Delivery Of iRGD-Modified Polymeric Nanoparticles For Boron Neutron Capture Therapy
- (2019) Jiejian Chen et al. International Journal of Nanomedicine
- Co-Administration Of iRGD Enhances Tumor-Targeted Delivery And Anti-Tumor Effects Of Paclitaxel-Loaded PLGA Nanoparticles For Colorectal Cancer Treatment
- (2019) Yi Zhong et al. International Journal of Nanomedicine
- An iRGD-conjugated prodrug micelle with blood-brain-barrier penetrability for anti-glioma therapy
- (2019) Lu Lu et al. BIOMATERIALS
- Cancer-targeted PEDF-DNA therapy for metastatic colorectal cancer
- (2019) Xingting Bao et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Transarterial Infusion of iRGD-Modified ZrO2 Nanoparticles with Lipiodol Improves the Tissue Distribution of Doxorubicin and Its Antitumor Efficacy
- (2019) Yang Xie et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Cancer Targeted Gene Therapy for Inhibition of Melanoma Lung Metastasis with eIF3i shRNA Loaded Liposomes
- (2019) Wen Xiao et al. MOLECULAR PHARMACEUTICS
- iRGD-guided tamoxifen polymersomes inhibit estrogen receptor transcriptional activity and decrease the number of breast cancer cells with self-renewing capacity
- (2019) María Inés Diaz Bessone et al. JOURNAL OF NANOBIOTECHNOLOGY
- Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study
- (2018) Anas M. Saad et al. BMC CANCER
- Nanoparticles that reshape the tumor milieu create a therapeutic window for effective T cell therapy in solid malignancies
- (2018) Fan Zhang et al. CANCER RESEARCH
- Co-administration of iRGD with peptide HPRP-A1 to improve anticancer activity and membrane penetrability
- (2018) Cuihua Hu et al. Scientific Reports
- Co-administration of biocompatible self-assembled polylactic acid–hyaluronic acid block copolymer nanoparticles with tumor-penetrating peptide-iRGD for metastatic breast cancer therapy
- (2018) Caifeng Deng et al. Journal of Materials Chemistry B
- Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
- (2018) Judith A. Seidel et al. Frontiers in Oncology
- Chemotherapeutic resistance: a nano-mechanical point of view
- (2018) Collins Otieno Nyongesa et al. BIOLOGICAL CHEMISTRY
- Immunomodulators targeting the PD-1/PD-L1 protein-protein interaction: From antibodies to small molecules
- (2018) Jeffrey Yang et al. MEDICINAL RESEARCH REVIEWS
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- Comment on “Coadministration of iRGD with Multistage Responsive Nanoparticles Enhanced Tumor Targeting and Penetration Abilities for Breast Cancer Therapy”
- (2018) Channakeshava Sokke Umeshappa et al. ACS Applied Materials & Interfaces
- iRGD-modified lipid–polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability
- (2017) Fei Gao et al. International Journal of Nanomedicine
- Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer
- (2017) Xiangsheng Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- iRGD as a tumor-penetrating peptide for cancer therapy
- (2017) Hong Yin et al. Molecular Medicine Reports
- Lipid–Drug Conjugate for Enhancing Drug Delivery
- (2017) Danielle Irby et al. MOLECULAR PHARMACEUTICS
- Exploring the Role of RGD-Recognizing Integrins in Cancer
- (2017) Markus Nieberler et al. Cancers
- Development of a multi-target peptide for potentiating chemotherapy by modulating tumor microenvironment
- (2016) Xu Song et al. BIOMATERIALS
- iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes
- (2016) Lorena Simón-Gracia et al. BIOMATERIALS
- Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00
- (2016) Giancarlo Pruneri et al. BREAST CANCER RESEARCH AND TREATMENT
- Elevated regulatory T cells, surface and intracellular CTLA-4 expression and interleukin-17 in the lung cancer microenvironment in humans
- (2016) Iwona Kwiecien et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Molecular imaging-guided photothermal/photodynamic therapy against tumor by iRGD-modified indocyanine green nanoparticles
- (2016) Fei Yan et al. JOURNAL OF CONTROLLED RELEASE
- iRGD-mediated core-shell nanoparticles loading carmustine and O6-benzylguanine for glioma therapy
- (2016) Chang Liu et al. JOURNAL OF DRUG TARGETING
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- (2016) Jonathan E Rosenberg et al. LANCET
- Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
- (2016) Andrea Wang-Gillam et al. LANCET
- Inducing Optimal Antitumor Immune Response through Coadministering iRGD with Pirarubicin Loaded Nanostructured Lipid Carriers for Breast Cancer Therapy
- (2016) Caifeng Deng et al. MOLECULAR PHARMACEUTICS
- Tumor-penetration and antitumor efficacy of cetuximab are enhanced by co-administered iRGD in a murine model of human NSCLC
- (2016) Yang Zhang et al. Oncology Letters
- Novel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinoma
- (2016) Pratiek N. Matkar et al. Oncotarget
- iRGD-mediated reduction-responsive DSPE–PEG/LA–PLGA–TPGS mixed micelles used in the targeted delivery and triggered release of docetaxel in cancer
- (2016) Lu Wang et al. RSC Advances
- Core-shell nanocarriers with high paclitaxel loading for passive and active targeting
- (2016) Zhu Jin et al. Scientific Reports
- A Novel Strategy through Combining iRGD Peptide with Tumor-Microenvironment-Responsive and Multistage Nanoparticles for Deep Tumor Penetration
- (2015) Xingli Cun et al. ACS Applied Materials & Interfaces
- Regulation of PD-L1: a novel role of pro-survival signalling in cancer
- (2015) J. Chen et al. ANNALS OF ONCOLOGY
- Multifunctional porous silicon nanoparticles for cancer theranostics
- (2015) Chang-Fang Wang et al. BIOMATERIALS
- Antitumor Immunity Triggered by Melphalan Is Potentiated by Melanoma Cell Surface-Associated Calreticulin
- (2015) A. M. Dudek-Peri et al. CANCER RESEARCH
- Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
- (2015) O. van Tellingen et al. DRUG RESISTANCE UPDATES
- Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor
- (2015) Xiaoyu Li et al. International Journal of Nanomedicine
- Co-administration of iRGD enhancing the anticancer efficacy of cisplatin-loaded polypeptide nanoparticles
- (2015) Haiyang Yu et al. JOURNAL OF CONTROLLED RELEASE
- A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis
- (2015) Kazuki N. Sugahara et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticles coated with the tumor-penetrating peptide iRGD reduce experimental breast cancer metastasis in the brain
- (2015) Amanda M. Hamilton et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Convection-enhanced delivery for the treatment of glioblastoma
- (2015) M. A. Vogelbaum et al. NEURO-ONCOLOGY
- A Novel Strategy to Improve the Therapeutic Efficacy of Gemcitabine for Non-Small Cell Lung Cancer by the Tumor-Penetrating Peptide iRGD
- (2015) Qing Zhang et al. PLoS One
- Age and Cancer Risk
- (2014) Mary C. White et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Correlation between the expression of integrins in prostate cancer and clinical outcome in 1284 patients
- (2014) Katharina Heß et al. Annals of Diagnostic Pathology
- Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates
- (2014) Ke Wang et al. BIOMATERIALS
- Anticancer effects of gemcitabine are enhanced by co-administered iRGD peptide in murine pancreatic cancer models that overexpressed neuropilin-1
- (2014) Y Akashi et al. BRITISH JOURNAL OF CANCER
- Trafficking of T Cells into Tumors
- (2014) C. Y. Slaney et al. CANCER RESEARCH
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer
- (2014) Anna Sophie Berghoff et al. CLINICAL & EXPERIMENTAL METASTASIS
- Anin vitrostudy on the effect of vinca alkaloid, vinorelbine, on chromatin histone, HMGB proteins and induction of apoptosis in mice non-adherent bone marrow cells
- (2014) Azra Rabbani-Chadegani et al. DRUG AND CHEMICAL TOXICOLOGY
- A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma
- (2014) Wenbing Dai et al. DRUG DELIVERY
- Integrins αvβ3 and αvβ5 as prognostic, diagnostic, and therapeutic targets in gastric cancer
- (2014) Christine Böger et al. Gastric Cancer
- Current approaches to enhance CNS delivery of drugs across the brain barriers
- (2014) Cui-Tao Lu et al. International Journal of Nanomedicine
- Surface Tailoring of Nanoparticles via Mixed-Charge Monolayers and Their Biomedical Applications
- (2014) Xiangsheng Liu et al. Small
- The Effect of Superparamagnetic Iron Oxide with iRGD Peptide on the Labeling of Pancreatic Cancer CellsIn Vitro: A Preliminary Study
- (2014) Hou Dong Zuo et al. Biomed Research International
- Targeting peptide iRGD-conjugated amphiphilic chitosan-co-PLA/DPPE drug delivery system for enhanced tumor therapy
- (2014) Xin Nie et al. Journal of Materials Chemistry B
- Chemotherapy-induced myeloid suppressor cells and antitumor immunity: The Janus face of chemotherapy in immunomodulation
- (2014) Zhi-Chun Ding et al. OncoImmunology
- Cyclic RGD-Linked Polymeric Micelles for Targeted Delivery of Platinum Anticancer Drugs to Glioblastoma through the Blood–Brain Tumor Barrier
- (2013) Yutaka Miura et al. ACS Nano
- iRGD-coupled responsive fluorescent nanogel for targeted drug delivery
- (2013) Shishuai Su et al. BIOMATERIALS
- The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells
- (2013) Guangzhi Gu et al. BIOMATERIALS
- The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation
- (2013) Xuan Zhang et al. International Journal of Nanomedicine
- iRGD Conjugated TPGS Mediates Codelivery of Paclitaxel and Survivin shRNA for the Reversal of Lung Cancer Resistance
- (2013) Jianan Shen et al. MOLECULAR PHARMACEUTICS
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cellular Density Effect on RGD Ligand Internalization in Glioblastoma for MRI Application
- (2013) Damien Moncelet et al. PLoS One
- Integrins and their ligands are expressed in non-small cell lung cancer but not correlated with parameters of disease progression
- (2013) Christine Böger et al. VIRCHOWS ARCHIV
- Enhanced Therapeutic Efficacy of iRGD-Conjugated Crosslinked Multilayer Liposomes for Drug Delivery
- (2013) Yarong Liu et al. Biomed Research International
- Pancreatic cancer: why is it so hard to treat?
- (2013) Paul E. Oberstein et al. Therapeutic Advances in Gastroenterology
- Strategies to Increase Drug Penetration in Solid Tumors
- (2013) Il-Kyu Choi et al. Frontiers in Oncology
- Peptides as Targeting Elements and Tissue Penetration Devices for Nanoparticles
- (2012) Erkki Ruoslahti ADVANCED MATERIALS
- De Novo Design of a Tumor-Penetrating Peptide
- (2012) L. Alberici et al. CANCER RESEARCH
- Dose-Dense Chemotherapy Improves Mechanisms of Antitumor Immune Response
- (2012) C.-L. Chang et al. CANCER RESEARCH
- Coadministration of Epithelial Junction Opener JO-1 Improves the Efficacy and Safety of Chemotherapeutic Drugs
- (2012) I. Beyer et al. CLINICAL CANCER RESEARCH
- Guanine Nucleotide-Binding Protein Gαi2: A New Partner of Claudin-5 that Regulates Tight Junction Integrity in Human Brain Endothelial Cells
- (2012) Anny-Claude Luissint et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Drug Transport across the Blood–Brain Barrier
- (2012) William M Pardridge JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- The disturbed blood–brain barrier in human glioblastoma
- (2012) Hartwig Wolburg et al. MOLECULAR ASPECTS OF MEDICINE
- nab -Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer
- (2012) Kristopher K. Frese et al. Cancer Discovery
- A tumor-penetrating peptide modification enhances the antitumor activity of endostatin in vivo
- (2011) Zhang Hai-Tao et al. ANTI-CANCER DRUGS
- Binding of a C-End Rule Peptide to the Neuropilin-1 Receptor: A Molecular Modeling Approach
- (2011) Nurit Haspel et al. BIOCHEMISTRY
- The effect of hydrophilic chain length and iRGD on drug delivery from poly(ε-caprolactone)-poly(N-vinylpyrrolidone) nanoparticles
- (2011) Zhenshu Zhu et al. BIOMATERIALS
- Epithelial Junction Opener JO-1 Improves Monoclonal Antibody Therapy of Cancer
- (2011) I. Beyer et al. CANCER RESEARCH
- In situ force mapping of mammary gland transformation
- (2011) Jose I. Lopez et al. Integrative Biology
- Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
- (2011) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted drug delivery to tumors: Myths, reality and possibility
- (2011) You Han Bae et al. JOURNAL OF CONTROLLED RELEASE
- Multimerization of Adenovirus Serotype 3 Fiber Knob Domains Is Required for Efficient Binding of Virus to Desmoglein 2 and Subsequent Opening of Epithelial Junctions
- (2011) H. Wang et al. JOURNAL OF VIROLOGY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Structure and Functions of P-Glycoprotein
- (2010) Y. Li et al. CURRENT MEDICINAL CHEMISTRY
- To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
- (2010) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14
- (2010) Hongjie Wang et al. NATURE MEDICINE
- Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy
- (2010) N. Kolishetti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
- (2010) K. N. Sugahara et al. SCIENCE
- Tumor-Penetrating Peptides: A Shift from Magic Bullets to Magic Guns
- (2010) O. Feron Science Translational Medicine
- Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
- (2009) Kazuki N. Sugahara et al. CANCER CELL
- Is Anticancer Drug Development Heading in the Right Direction?
- (2009) Trevor W. Hambley CANCER RESEARCH
- Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
- (2009) Kandice R. Levental et al. CELL
- Role of Class 3 Semaphorins and Their Receptors in Tumor Growth and Angiogenesis
- (2009) P. Gaur et al. CLINICAL CANCER RESEARCH
- Adhesion signaling - crosstalk between integrins, Src and Rho
- (2009) S. Huveneers et al. JOURNAL OF CELL SCIENCE
- New targeted probes for radioimaging of angiogenesis
- (2009) T.H. Stollman et al. METHODS
- C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration
- (2009) T. Teesalu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo
- (2008) Sara Gosk et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion
- (2008) B. Kavanagh et al. BLOOD
- Expression of Integrin αvβ3in Gliomas Correlates with Tumor Grade and Is not Restricted to Tumor Vasculature
- (2008) Oliver Schnell et al. BRAIN PATHOLOGY
- Tumour-targeted nanomedicines: principles and practice
- (2008) T Lammers et al. BRITISH JOURNAL OF CANCER
- Vascular Endothelial Growth Factor and Semaphorin Induce Neuropilin-1 Endocytosis via Separate Pathways
- (2008) Anna Salikhova et al. CIRCULATION RESEARCH
- Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
- (2008) H. Maeda et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Drug targeting and tumor heterogeneity
- (2008) You Han Bae JOURNAL OF CONTROLLED RELEASE
- Environmental sensing through focal adhesions
- (2008) Benjamin Geiger et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now